Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: Cellular transformation and invasion

Journal of the National Cancer Institute

Volumn 89, Issue 8, 1997, Pages 567-571

  Kubota, Shunichiro ^a   Kiyosawa, Haruo ^a   Nomura, Yukihiro ^a   Yamada, Takeshi ^a   Seyama, Yousuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ORNITHINE DECARBOXYLASE;

ANIMAL CELL; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL GROWTH; CELL STRAIN 3T3; CELL TRANSFORMATION; ENZYME ACTIVITY; ENZYME INDUCTION; FIBROBLAST; GENE EXPRESSION REGULATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 0030935710     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.8.567     Document Type: Article

References (26)

1. Liotta LA. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986;46:1-7.
2. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-5.
3. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726-35.
4. Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995; 55:4182-7.
5. Cowley S, Paterson H, Kemp P, Marshal CJ. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994;77: 841-52.
6. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994;265: 966-70.
7. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988;48:759-74.
8. Auvinen M, Paasinen A, Andersson LC, Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992;360: 355-8.
9. Moshier JA, Dosescu J, Skunca M, Luk GD. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res 1993;53:2618-22.
10. Shantz LM, Pegg AE. Overexpression of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 1994;54:2313-6.
11. Kubota S, Ohsawa N, Takaku F. Effects of DL-alpha-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo. Int J Cancer 1987;39:244-7.
12. Kubota S, Yamada T, Kamei S, Seyama Y. Ornithine decarboxylase is directly involved in mouse mammary carcinoma cell invasion in vitro. Biochem Biophys Res Commun 1995; 208:1106-15.
13. van Steeg H, van Oostrom CT, Hodemaekers HM, van Kreyl CF. Cloning and functional analysis of the rat ornithine decarboxylase-encoding gene. Gene 1990;93:249-56.
14. van Kranen HJ, van de Zande L, van Kreijl CF, Bisschop A, Wieringa B. Cloning and nucleotide sequence of rat ornithine decarboxylase cDNA. Gene 1987;60:145-55.
15. Takebe Y, Seiki M, Fujisawa J, Hoy P, Yokota K, Yoshida M, et al. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1988;8:466-72.
16. Landolph JR. Mechanisms of chemically induced multistep neoplastic transformation in C3H 10T 1/2 cells. Carcinog Compr Surv 1985;10:211-23.
17. Gorman C, Padmanabhan R, Howard BH. High efficiency DNA-mediated transformation of primate cells. Science 1983;221:551-3.
18. Murakami Y, Marumo M, Hayashi S. Ornithine decarboxylase antizyme in kidneys of male and female mice. Biochem J 1988;254: 367-72.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
20. Kubota S, Takeda K, Yamada T, Nomura Y, Takeda M, Iwamoto S, et al. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion. Cancer Lett 1996;98: 233-40.
21. Gotoh Y, Nishida E, Yamashita T, Hoshi M, Kawakami M, Sakai H. Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells. Eur J Biochem 1990;193:661-9.
22. Clifford A, Morgan D, Yuspa SH, Soler AP, Gilmour S. Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res 1995;55: 1680-6.
23. Auvinen M, Paasinen-Sohns A, Hirai H, Andersson LC, Holtta E. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130cas. Mol Cell Biol 1995;15:6513-25.
24. Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, et al. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res 1987;47:1523-8.
25. Ballin M, Gomez DE, Sinha CC, Thorgeirsson UP. Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem Biophys Res Commun 1988;154:832-8.
26. Leevers SJ, Marshall CJ. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J 1992;11:569-74.